Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

11.1%

1 terminated/withdrawn out of 9 trials

Success Rate

85.7%

-0.8% vs industry average

Late-Stage Pipeline

11%

1 trials in Phase 3/4

Results Transparency

0 of 6 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A

4(50.0%)

Phase 2

3(37.5%)

Phase 3

1(12.5%)

8Total

N/A(4)

Phase 2(3)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT04318041Phase 3Recruiting

Evaluation of the Structural Modification Effect of Diacerein (Artrodar®) in Knee Osteoarthritic Patients

Role: lead

NCT03984955Not ApplicableRecruiting

Comparing Injection Treatments for Tennis Elbow

Role: collaborator

NCT04866706Completed

Performance and Safety of Routine Cataract Surgery With Visiol

Role: lead

NCT02335034Not ApplicableCompleted

Project Arthritis Recovering Quality of Life by Means Education II (PARQVE II)

Role: collaborator

NCT03460548Not ApplicableTerminated

REMOGEN® Omega Versus Cationorm® in the Treatment of Patients Suffering From Dry Eye

Role: lead

NCT03203408Not ApplicableCompleted

Efficacy of OSTENIL PLUS (Hyaluronic Acid) Versus SYNVISC-ONE in Patients With Tibiofemoral Osteoarthritis

Role: lead

NCT01264211Phase 2Completed

Safety and Efficacy of the Combination of Diacerein 100 mg Daily and MTX Versus MTX Alone in the Treatment of Early Rheumatoid Arthritis (RA)

Role: lead

NCT01267214Phase 2Completed

The Efficacy and Safety of Intraarticular Sodium Hyaluronate (Hyalgan) After Proximal Tibial Osteotomy in Treatment of Knee Osteoarthritis Patients

Role: lead

NCT01288001Phase 2Completed

Study of Evaluating the Duration of Efficacy of One Intra Articular Injection of Sodium Hyaluronate 2.0% in Patients With Painful Osteoarthritis of the Knee

Role: lead

All 9 trials loaded